Merck & Co. Inc. v. Gilead Sciences Inc.

Certiorari Denied

Petition for certiorari denied on January 7, 2019.

Docket No.18-378

Op. BelowFed. Cir.

Issue

Whether the equitable defense of unclean hands precludes legal relief in the form of damages.

Proceedings & orders timeline

Application (18A51) to extend the time to file a petition for a writ of certiorari from July 24, 2018 to September 21, 2018, submitted to The Chief Justice.

Jul 16, 2018

Application (18A51) granted by The Chief Justice extending the time to file until September 21, 2018.

Petition for a writ of certiorari filed. (Response due October 24, 2018)Oct 11, 2018

Motion to extend the time to file a response from October 24, 2018 to November 23, 2018, submitted to The Clerk.

Oct 15, 2018

Motion to extend the time to file a response is granted and the time is extended to and including November 23, 2018.

Brief amicus curiae of Samuel L. Bray filed.Oct 24, 2018

Brief amicus curiae of Celgene Corporation filed.Nov 14, 2018

Brief of respondent Gilead Sciences, Inc. in opposition filed.Nov 27, 2018

Reply of petitioners Merck & Co., Inc., et al. filed.

Nov 28, 2018

DISTRIBUTED for Conference of 1/4/2019.

Jan 7, 2019

Petition DENIED.

Recommended Citation: Merck & Co. Inc. v. Gilead Sciences Inc., SCOTUSblog, https://www.scotusblog.com/cases/merck-co-inc-v-gilead-sciences-inc/